3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
10
Wilms Tumor
9
Leukemia, Myeloid, Acute
9
Osteosarcoma
8
Neuroblastoma
8
Neoplasm Metastasis
8
Multiple Myeloma
8
Lung Neoplasms
8
Glioma
8
Sarcoma
7
Rhabdoid Tumor
7
Lymphoma, Non-Hodgkin
7
Hepatoblastoma
7
Carcinoma, Hepatocellular
7
Rhabdomyosarcoma
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Myelodysplastic Syndromes
6
Medulloblastoma
6
Lymphoma
6
Histiocytosis, Langerhans-Cell
6
Ependymoma
6
Colorectal Neoplasms
6
Breast Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Melanoma
5
Central Nervous System Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Sarcoma, Ewing
4
Ovarian Neoplasms
4
Endometrial Neoplasms
4
Interventions
asciminib
15
Cyclophosphamide
12
fludarabine phosphate
10
Mycophenolic Acid
9
fludarabine
8
nilotinib
7
Whole-Body Irradiation
7
Imatinib Mesylate
6
Dasatinib
6
Tacrolimus
5
Sirolimus
5
Cyclosporine
5
venetoclax
4
bosutinib
4
Melphalan
4
Granulocyte Colony-Stimulating Factor
4
ponatinib
3
Thiotepa
3
Stem Cell Transplantation
3
Peripheral Blood Stem Cell Transplantation
3
Cyclosporins
3
Busulfan
3
thymoglobulin
2
ruxolitinib
2
Specimen Handling
2
Mesna
2
Magnetic Resonance Spectroscopy
2
Filgrastim
2
Blood Component Removal
2
treosulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
X-Rays
×
90 days
×
Clear all
No trials found.